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Progress in the ﬁeld of cardiovascular devices has signiﬁcantly contributed to the rapid advancements in cardiovascular disease therapy during
the last ﬁfty years. However, friction and wear occurring at cardiovascular devices may cause a failure of the implanted devices, or some serious
complications, such as hemolysis, thrombus formation and so on. Tribology study in cardiovascular devices belongs to the research range of bio-
tribology which deals with all aspects of tribology concerned with biological systems. In this paper, the study situation of bio-tribology at
cardiovascular devices is brieﬂy reviewed. First, typical tribological problems in various cardiovascular devices are analyzed. Then, the methods
of anti-wear and anti-friction in cardiovascular devices are presented, and the research progress in the lubrication property of human blood is
summarized. Last, some suggestions and prospects for future research are put forward.
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Every day, a healthy human heart pumps 7500 l of blood
through 96,000 km of blood vessel. Given this demanding
workload, the development of cardiovascular disease is not
surprising [1]. As lifetime of people increases, the number of
patients with cardiovascular disease is growing. However,
mortality from cardiovascular disease has declined remarkably
in the recent decades. It has been reported that the U.S. age-
adjusted mortality from cardiovascular disease declined 50% in
the recent thirty-ﬁve years [2]. One of the most important
reasons for this marked reduction is the application of
implanted cardiovascular devices [2]. For example, artiﬁcial
heart valves (AHVs) are used to replace damaged or diseased
natural valves resulting in signiﬁcant improvement of life span
and quality of life [3–6]. Synthetic vascular grafts (SVG) are
used to repair weakened blood vessels and to bypass
blockages, resulting in an enhanced blood ﬂow to malperfused
organs and limbs [7–11]. In order to improve the pumping
function of the heart, intra-aortic balloon pumps, ventricular
assist devices (VADs) [12,13], total implantable artiﬁcial
hearts (TAH) [14,15], etc. are being used. Pacemakers
[16,17] and automatic internal deﬁbrillators [18] are widely
used to override or correct aberrant, life-threatening cardiac
arrhythmias. In addition, life threatening occlusive diseases of
the arteries are treated by implantation of intravascular stents
[19–21] which are inserted into the body passages using a
catheter to maintain the ﬂow of blood, etc.
Safety of cardiovascular devices has been emphasized both
concerning biological aspects and mechanical aspects. Various
investigations have analyzed the impact of infection, thrombus,
chemical degradation, wear and fatigue, et al. as reasons for the
failure of implanted devices. Obviously, wear and friction will
occur at artiﬁcial heart valves or ventricular assist device
which include moving components. Actually, friction also
occurs at intravascular stents or vascular grafts which have no
moving components. In this condition, the blood cells them-
selves are part of the frication pair.
During their function in situ, the cardiovascular devices are
permanently in contact with human blood. As human blood is
a biological system, tribological problems in blood fall into the
ﬁeld of bio-tribology, a term which was ﬁrst introduced by
Dowson and Wright in 1973 [22]. Now, bio-tribology is one of
the most exciting and rapidly growing areas of tribology [23].
There is many published literature which report the wear and
friction at many kinds of cardiovascular devices, however
there appears to be no thorough review especially dedicated to
tribology in cardiovascular devices. The aim of this paper
is to review the current status of tribology research in
cardiovascular devices. First, typical tribological problems incardiovascular devices will be analyzed, then the methods of
anti-wear and anti-friction in cardiovascular devices are pre-
sented, and the research progress in the lubrication property of
human blood is summarized. Last some suggestions and
prospects for further research are put forward.2. Tribological problems in cardiovascular devices
Tribological problems in cardiovascular devices can be
divided into three types according to the different friction
pairs. First, the moving components in cardiovascular devices
produce mechanical wear and friction, such as artiﬁcial heart
valves and ventricular assist device. Second, the blood ﬂow
produces ﬂuid-friction on the surface of all kinds of cardio-
vascular devices. Thirdly, during the implanting or the regular
function in situ, friction occurs between the devices and human
soft tissue.2.1. Mechanical wear and friction
2.1.1. Artiﬁcial heart valves
An artiﬁcial heart valve is a device implanted in the heart of
a patient with vascular heart disease. There are two basic types
of artiﬁcial heart valves: mechanical heart valves (MHVs) and
bioprosthetic heart valves (BHVs). MHVs have three major
types: caged-ball, tilting-disk and bileaﬂets with many mod-
iﬁcations on these designs. BHVs come from the valves of
animals, like pigs or cattle, which undergo several chemical
procedures in order to make them suitable for implantation in
the human heart. Since the loading forces for BHVs are one
order of magnitude lower than for MHVs [86], the behaviors
of mechanical wear and friction in BHVs should be much
more slight than that in MHVs. It is indeed that there is very
few literature which discussed the mechanical wear and
friction in BHVs. Most studies on BHVs are focused on their
calciﬁcation behavior which is thought as the main reason for
the failure in vivo service. However, mechanical wear and
friction has always been an important research subject in the
ﬁeld of MHVs. The mechanical wear in MHVs includes
impact wear and friction wear [24]. Impact wear usually
occurs in the hinge regions of bileaﬂets, between the occluder
and the ring in tilting-discs, and between the ball and cage in
caged-ball valves [25]. At the same time, friction wear occurs
between occluder and struts in tilting discs and between leaﬂet
pivots and hinge cavities in bileaﬂets [26].
The excessive mechanical wear may cause the failure of
MHVs, e.g. strut fracture or the leaﬂet escape. Zhang et al. [27]
reported a case that a leaﬂet escape occurred in a low proﬁle
bileaﬂet mechanical prosthesis, which had been implanted for
3 years in the mitral position of a 32 year old patient. The
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bifurcation ﬁnally. The leaﬂet was observed to be missing the
major part of one ear, which is the protrusion or tab at the base
of the leaﬂet that provides the pivot point to maintain the
leaﬂet in the oriﬁce, as shown in Fig. 1 [27]. Large surface
chippings were associated with this missing ear on the leaﬂet
outﬂow side of the valve and signiﬁcantly smaller chippings
on the inﬂow side. The uneven appearance of the outﬂow edge
suggested an excessive wear during the closing phase of valve
operation. According to the report of Mert et al. [28], there
were 46 leaﬂets escaped out of 200,000 implants of the
Edwards-Duromedics bileaﬂet valve.Fig. 1 Gross observation of an escaped heart valve leaﬂet. The section with the
missing ear is associated with large chipping on the outﬂow surface (double
arrows) and signiﬁcantly smaller chipping on the inﬂow surface (single arrow)
[27].
Fig. 2 Photograph of a removed aortic valve prosthesis, showing severely disrupted
top of excised Starr-Edwards valve). Arrows indicate exposure of the metal on the or
[32].In cloth-covered cardiac valve prostheses, cloth-wear is also
prone to occur [29]. Serious cloth-wear may cause hemolysis,
prosthetic insufﬁciency, and/or embolism [30,31]. Murakami
et al. [32] reported a case that a patient developed severe
hemolytic anemia 23 years after insertion of a cloth-covered
Starr-Edwards model 2320 aortic valve prosthesis. The pros-
thesis showed no sign of signiﬁcant dysfunction. Upon
removal, it showed extensive cloth wear on the inner surface
of all three struts, one strut was completely denuded of its cloth
covering, as shown in Fig. 2 [32]. Hemolysis problems in this
patient immediately were resolved after replacement with a St.
Jude aortic prosthesis.
2.1.2. Ventricular assist devices
Ventricular assist devices (VADs) are designed to augment
or replace the function of one or more chambers of the failing
heart. The two main varieties of VADs are pulsatile pumps and
the more recent continuous ﬂow pumps i.e. rotary pumps [33].
Pulsatile pumps, have an inherently large tissue and blood
contacting surface and have multiple moving mechanical parts
including actuator bearing, direction valves, motor, pusher etc.
Mechanical wear and friction occur at all surfaces of compo-
nents moving against each other. Rotary pumps utilize an
impeller to pump blood which is constrained by mechanical
contact bearings [34]. According to the direction to which the
blood enters and leaves the impeller, the impeller can be
termed axial, radial (centrifugal), or mixed ﬂow. Rotary pumps
are becoming more popular because they contain fewer
moving parts, thereby increasing mechanical reliability and
longevity of performance [35]. In addition, rotary pumps
consume less power, they are powered by electrical unit ratherfabric because of wear (left panel: side vies; upper right panel: view from the
iﬁce ring where the poppet seats at the time of valve closure (lower right panel)
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pulsatile pumps. The design offers greater comfort and
increased mobility for patients. The continuous ﬂow method
provides vascular perfusion equivalent to that provided by
pulsatile pumps [35].
Various type of bearing system have been used in VADs
with different operation conditions. Mechanical friction and
wear mainly occur in these bearing system. Some externally
VADs which use rotary blood pumps have small rolling
element bearings such as ball bearings [36]. Rolling element
bearings require a shaft seal to prevent blood entering the
bearing voids between the rolling elements. If blood enters the
bearing voids, it coagulates and may cause bearing seizure by
interfering with the rolling elements [37]. Although the friction
pairs in this bearings system do not contact with blood in this
case, it is noted that the heat produced by friction can also
cause hemolysis in the sealed ball bearings system.
Some implantable blood pumps utilize pivot bearings [38–
41]. Pivot bearings can operate immersed in blood without a
blood seal. In this condition, blood acts as a lubricant, and the
tribological behavior of the pivot bearings is consistent with
boundary lubrication behaviors [42]. However, the load-
bearing blood ﬂuid ﬁlm is prone to higher shear stress [43],
and theoretically, more hemolysis can occur.
Other blood pump bearing systems utilize journal bearings
ﬂushed with ﬂuids such as saline solution or blood [44].
Journal bearings have minimal wear, but require a separate
thrust bearing that complicates pump design. Journal bearings
require ﬂuid pressure to support the loads. If the pump utilizes
saline solution rather than blood as the bearing ﬂuid, then
pump design is signiﬁcantly complicated by the need for a
separate reservoir, ﬂow lines, and the like. If the pump utilizes
blood as bearing ﬂuid, then potential pump seizure caused by
coagulated blood is a serious concern.
In general, a contacting seal with the shaft supported in ball
bearings or with a journal bearing lubricated by saline or
similar ﬂuid is disadvantageous in terms of wear and heat
generation. Many recent designs attempt to avoid the seal by
using small pivots [45].
The quantitative research about the wear and friction in
VADs are seldom reported. The most likely reason may
be the limitation of methodology. There are only very few
quantitative studies concerning the wear in VADs [42]. In the
most important article, Sundareswaran et al. used a surfaceFig. 3 (A) Proﬁlometer used for measuring bearing wear, photograph of the measure
paths that were used for evaluating the bearing wear along with labels of the fourproﬁlometer with sufﬁcient resolution to capture surface
irregularities of bearing ball in the submicron range, as shown
in Fig. 3 [42]. Geometric proﬁle variations measured on the
inlet bearing ball were used to calculate the wear. Bearing wear
was normalized to the total pump support duration to obtain an
annualized bearing wear rate. By this method, they found that
the bearing wear rate was less than 1.46 μm/yr and the
estimated bearing life of HMII pump was at least 17 years.
However, there were some limitations of this study. First,
bearing wear was determined using surface proﬁlometry at
pump explant but not during pump manufacture. Thus, the
degree of bearing wear already present at the time of device
implant could not be quantiﬁed, but it should be excluded
when estimating the bearing life. Second, wear was only
evaluated on the inlet bearing ball and not on the bearing cup.
This is a direct limitation of the proﬁlometry, as it cannot be
used to measure wear within a concave surface. Thirdly, the
evaluation of bearing life (from pumps implanted for more
than 1 year) assumed a linear bearing wear rate. But in fact it
appeared that bearing wear from early use to later use was
actually not linear, as the wear rate decreased considerably. So
establishment of more effective methods to evaluate the wear
extent of VADs is mandatory in the future research.
2.1.3. Vascular stents and vascular stent-grafts
When a stenotic vessel area is diffuse and cannot be covered
by a single stent or in the case of treating long or recurrent
lesions, typically, two or more overlapping stents are deployed
in the vessel [46–49]. A scheme of overlapping stents is shown
in Fig. 4 [50]. Fretting wear has been observed on overlapping
area of stents following fatigue simulation test, as shown in
Fig. 5 [50]. The pits, indicated by arrows in Fig. 5, present
fretting damage. This type of damage occurs when different
shear forces act on two overlapping stents by pulsed blood
ﬂow. Arterial curvature combined with overlapping stents
enhance the incidence and degree of wear compared to single
stents in a straight vessel conﬁguration [50].
Endovascular aneurysm repair (EVAR) is a type of endo-
vascular surgery used to treat abdominal aortic aneurysms
(AAA) [51,52]. The prosthesis used for this purpose, is called
vascular stent-graft [53,54]. The vascular stent-graft is a
tubular prosthetic vascular graft, constituted by two modules:
the graft and the stent. The graft is typically made of
polyethylene terephthalate (PET) commercially known asment setup with the stylus placed on the bearing ball (B), the two measurement
traces that are used for wear calculation (C) [42].
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reinforced by metallic struts (stents). These stents are usually
made of nitinol or stainless steel, and their upper ends can be
ﬁxed to the arterial wall [55]. In vivo service, the pulsatile ﬂow
of the aorta and the conﬁguration of the stent graft allow for
micromotion of the individual metal stents against the fabric
which leads to eventual breakdown and graft wear [56]. Fabric
wear and wear hole have been observed in an explanted
prosthesis at the site of graft to stent ﬁxation as shown in Fig. 6
[56]. The graft wear will induce a blood leakage which is the
major complication associated with endovascular aneurysm
repair (EVAR) [57].2.2. Fluid-friction in cardiovascular device
The blood ﬂow also engenders a frictional force on the
endothelial surface of the luminal vessel wall due to its
viscosity [58,59]. This ﬂuid-friction not only exists in the
cardiovascular organs, but also in the cardiovascular devices,
even if they have no moving components, such as vascular
grafts or vascular stents. Recent study indicates the stent
migration [60] and the corrosion behavior of absorbable
magnesium-based stents have relation to the ﬂuid-friction
induced by blood ﬂow [61]. It has to be pointed out that the
friction force acting on vessel wall cell per unit area are known
as wall shear stress in most literature, and in the following
discussion we will use the term shear stress instead of ﬂuid
friction.
Blood ﬂow induced shear stress exists in all kinds of
cardiovascular devices, and it has been studied frequently.Fig. 4 Scheme of overlapping stents [50].
Fig. 5 SEM of fretting wear area (arrow pointed) inThe magnitude of the shear stress can be estimated in most of
the vasculature by Poiseuille's law, and Poiseuille's law states
that shear tress is proportional to blood ﬂow viscosity, and
inversely proportional to the third power of the internal radius,
as shown in Fig. 7 [62]. Measurements using different
modalities show that shear stress ranges from 1 to 6 dyn/cm2
in the venous system and between 10 and 70 dyn/cm2 in the
arterial vascular network [63].
There are several threshold of shear stresses for physiolo-
gical response of blood cells. Studies have identiﬁed hemody-
namic shear stress is an important determinant of endothelial
function and phenotype [58,63–66]. Arterial-level shear stress
(415 dyn/cm2) induces endothelial quiescence and an ather-
oprotective gene expression proﬁle, while low shear stress
(o4 dyn/cm2), which is prevalent at atherosclerosis-prone
sites, stimulates an atherogenic phenotype [58]. It has also
been identiﬁed that platelets are activated and form micro-
particles in native blood under high shear stress [67]. The
required shear stress for platelet activation is above 100–
500 dyn/cm2 [68–71]. Turbulent shear stresses in mechanical
valve have been measured from 1500–3800 dyn/cm2 [72–75],
which obviously over the range of platelet activation [76,77].
Higher shear stress also damages the blood cells. Shear
stress below a critical level and exposure time results in elastic
deformation of the red blood cells, however, above that
threshold, hemoglobin leaks into the plasma [78], that is
hemolysis. This threshold of shear stress for hemolysis ﬁrst
was determined as 1500 dyn/cm2 reported by Leverett et al.
[79]. Now an often-cited threshold for hemolysis is 4000 dyn/
cm2 [80]. Considering turbulent environment, the hemolytic
threshold has been reevaluated as 6000–8000 dyn/cm2 by
Grigioni and Lu et al. [81,82].
In most commercial centrifugal blood pumps, Newtonian
shear stress remains in the range of 2000–1000 dyn/cm2 with
characteristic transition times of 1 s per passage. In small axial
pumps, however, shear stress is considerably higher and can
reach peak values of around 4000 dyn/cm2, while the transition
times are in the order of 1 ms [45]. According to Giersiepen et
al. [83] hemolysis and platelet activation are a function of both
shear stress level and transition time. Therefore, both com-
mercial pump types (centrifugal and axial pumps) principally
operate in regions of low cell destruction. However, there is a
trend to develop smaller size pumps to beneﬁt more heartthe overlapping region of overlapped stents [50].
Fig. 6 Clinical example of fatigue in Boston Scientiﬁc Vanguard endovascular graft. A sixty-nine year old man had the tube graft inserted for repair of abdominal
aortic aneurysm. (A) The graft was explanted, and conventional repair was done at 36 months. Arrow points to site of proximal row separation, (B) high-power
magniﬁcation of the graft depicted in (A) shows fabric fatigue and wear holes on the prosthesis surface [56].
Fig. 7 Hemodynamics of shear stress. Cross-sectional schematic diagram of a
blood vessel illustrating the hemodynamic shear stress τs, the frictional force
per unit area action on the inner vessel wall and on the luminal surface of the
endothelium as a result of the ﬂow of viscous blood [62].
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hydraulic output, have to operate at a higher rotational speed
because of the reduced impeller size. This gives rise to
increased wear at the mechanical bearings, a signiﬁcant
shear stress, and a high local temperature resulting from the
increased speed which can induce hemodynamic complica-
tions, e.g. hemolysis. The safe operational period of the
miniature pumps is thus still constrained [84].
In addition to red blood cells (RBCs) damage, shear stress
also reduces the ability of white blood cells (WBCs) to combatinfection [85]. The limited data on the effects of shear stress on
WBCs suggests that with an exposure time round 0.1 s, a shear
stress of 130 dyn/cm2 reduces phagocytosis, and shear stresses
above that impairs the cells further [85].
Some literature has discussed the leaﬂet skin friction that
occurs in BHVs [86]. Actually, leaﬂet skin friction is also a
ﬂuid friction which arises from the interaction between the
blood ﬂow and the skin of the leaﬂet, and is directly related to
the wetted surface area of the leaﬂet. Leaﬂet skin friction has a
signiﬁcant inﬂuence on the systolic performance of biopros-
thetic aortic valve based on ﬂuid structure interaction simula-
tions [86]. Higher leaﬂet skin friction has been found to
increase the systolic transvalvular pressure gradient and the
peak velocity through the valve, as well as decrease the valve
oriﬁce area. The results for the leaﬂet opening and closing
kinematics also show that higher leaﬂet skin friction combined
with higher leaﬂet stiffness produces longer rapid valve
opening, closing and ejection times, as well as smaller valve
oriﬁce areas. These results are consistent with clinical ﬁndings
for calciﬁed aortic valves and suggest that the valve perfor-
mance under stenotic conditions is strongly inﬂuenced by the
combined effect of increasing leaﬂet stiffness and surface
roughness caused by calciﬁcation.2.3. Friction between cardiovascular device and soft tissue
Because of the relative motion or relative movement trends,
friction also occurs between cardiovascular devices and the
tissue during the process of implanting or during the function
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between the catheter or stent and vessels.
Intravascular catheters have been used for the treatment of
various diseases, including acute infarction and aneurysms.
During the operating process, frictional forces applied by the
catheter on the blood vessel wall can induce vasoconstriction
and injury, which will result in reactive intimal proliferation or
distal embolization associated with end-organ ischemia and
infarction [87]. Winters et al. [88] also reported that intra-aortic
balloon catheters used for vascular applications, such as
arteriography and angioplasty, may cause vascular surgical
bleeding and need for vascular surgical repair due to high
friction between the catheter and blood vessel.
In most cases, friction in cardiovascular devices is an
undesired effect, with one major exception. Endovascular
aneurysm repair (EVAR), which is a less invasive procedure,
involves placing a stent-graft into the aneurysm to form an
artiﬁcial conduit which excludes the aneurysm sac from
pressure. Stent migration is a main complication of EVAR.
It is triggered when the repeated force applied by pulsatile
blood ﬂow exceeds the ﬁxation force between the stent-graft
and artery [89]. Resch et al. [90] reported that stent-graft
migration occurs in 45% of the patients after EVAR. Zarins et
al. [91] found that stent-graft migration occurred in 94 out of
1119 patients with a mean time of 30 months after device
implantation. They also indicated that with an increase in time
after EVAR, likelihood of migration increased, i.e., 1.4% at
1 year, 6.4% at 2 years, and 18.8% at 3 years. Schlensak et al.
[92] reported that serious complications related to stent-graft
migration was 13% of the patients during the ﬁrst 4 years, and
this was independent of the type of the implanted device. Lee
et al. [93] studied stent graft migration following EVAR and
reported that distal displacement greater than 1 cm was
correlated with the need for secondary intervention. Factors
that help maintaining the stent-graft position or prevent
migration are hook and barbs at the proximal and/or distal
end, stent-graft oversizing and favorable frictional interactions.
When severe aortic angulations is present, stent-grafts with
hooks do not improve ﬁxation [94]. Although stent-graft
oversizing has proven to be effective in increasing ﬁxation,
the excessive oversizing has been found to cause postoperative
neck dilation and may actually result in postoperative migra-
tions [95]. Conners et al. [96] indicated that migration was
signiﬁcantly associated with late aortic neck dilation. In such
case, static frictional interactions between stent and vessel are
critical factors that contribute to secure anchorage of the stent-
graft to the artery.
3. Method of anti-wear and anti-friction in cardiovascular
devices
There are two approaches to reduce the damage caused by
wear and friction in cardiovascular devices according to the
general tribology theory. One is from the aspect of material
science, such as selecting anti-friction materials to fabricate
friction pairs. The other considers the structure design. Both of
these approaches have advantages and disadvantages. The ﬁrstmethod is relatively simple and inexpensive in comparison
with the second one, but its challenge is that the selected
material needs to have both good blood comparability and
wear resistance.3.1. Materials
3.1.1. Optimization of friction pairs
The materials used in cardiovascular devices mainly include
metals, polymers and ceramics. However, none of them is
completely ideal. Some researchers have attempted to combine
different materials as friction pairs to reduce mechanical wear.
For example, Bock et al. [97] reported a new dual impeller
centrifugal blood pump with a double pivot bearing system.
Two types of pairs, ceramic–polymeric pairs and ceramic–
ceramic pairs, were tested by a wear test station to determine
their wear rate in blood. The polymers chosen were nylon,
UHMWPE, and Teﬂon. The ceramics chosen were zirconium
dioxide (ZrO2), silicon nitride (Si3N4), carbon, and alumina
(Al2O3). It was found the pairs composed of alumina and
UHMWPE had lowest wear rate, and can be chosen to be the
materials of the double pivot bearing system in order to avoid
vibration problems.
The introduction of pyrolitic carbon (PyC) as a valve
material is a breakthrough in the manufacture of MHVs.
PyC has a relatively good blood compatibility characteristics
and wear performance, and it can be used to fabricate
housings, hinges, leaﬂets and discs of MHVs. The wear rates
of different material couples (PyC–PyC, metal–PyC) have
been assessed by Arru and Shim et al. [98,99]. The results
show that the wear rate of PyC–PyC is slightly lower than that
of PyC–Metal, but both of them are very low. The ﬁrst valve to
employ a PyC–PyC couple is the St. Jude Medical valve,
which has ﬁxed pivots for the leaﬂets. Wear tests on this valve
indicate that it would take 200 years to wear halfway through
the PyC coating on a leaﬂet pivot [100].3.1.2. Surface modiﬁcation
Surface modiﬁcation technology has been used to improve
the tribological performance of cardiovascular devices for a
long time. Mal’gichev et al. [101] reported that DLC coatings,
which had excellent wear resistance and biocompatibility can
improve tribotechnical parameters of pump bearings and thus
they were used to develop wear resistance friction pairs.
Jahanmir et al. [102] reported that heparin treated H-DLC
coatings on blood pump surfaces allowed the development of
cardiovascular devices with reduced potential for wear and
hemolysis, both considered as major impediments in the use of
medical devices. Tang et al. [103] reported molybdenum
doped diamond like carbon (Mo-DLC) coatings with improved
mechanical and blood compatibility properties were deposited
by closed ﬁeld unbalanced magnetron sputtering. The Mo-
DLC nanocomposite coatings would be a new kind of
promising material applied to artiﬁcial heart valves and
endovascular stents. DLC coated heart valves and stents are
already commercially available [104].
Fig. 8 Artiﬁcial heart valve modiﬁed by TiO2/TiN duplex ﬁlms [105].
Fig. 9 Abrasion of an artiﬁcial heart valve bracket [105]: (a) heart valve
modiﬁed by TiO2/TiN duplex ﬁlm, (b) bare titanium alloy artiﬁcial heart valve
bracket.
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sized on Ti6Al4V artiﬁcial heart valves as shown in Fig. 8
[105]. The fatigue property of the TiO2/TiN duplex ﬁlm was
studied in an artiﬁcial heart valve fatigue tester. The artiﬁcial
heart valve was opened and closed 38,340,000 fatigue test
cycles, no visible abrasion was found on the surface of the
artiﬁcial heart valve bracket (indicated by the arrow in Fig. 8)
coated with the TiO2/TiN duplex ﬁlm, as shown in Fig. 9a
[105]. An artiﬁcial heart valve of titanium alloy without such
coating was only opened and closed 18,540,000 fatigue test
cycles, then severe abrasion was found on the titanium alloy
brackets, as shown in Fig. 9b [105]. Thus, the fatigue and wear
property of the artiﬁcial heart valve with a TiO2/TiN duplex
ﬁlm was signiﬁcantly improved, compared with the artiﬁcial
heart valve of bare titanium alloy [105].
Surface modiﬁcation technology was also used to develop
low frictional catheters. Ho et al. [106] reported that a
2.5 mm uniform coating of poly(2-methacryloyloxyethyl phos-
phorylcholine-co-n-butyl methacrylate [poly(MPC-co-BMA)]
was coated on a polyurethane (PU) catheter material using dip
casting technique. Compared with uncoated PU, the coating on
PU substrate offered the least frictional resistance which
resulted from the hydration of the phosphorylcholine polymer
and boundary lubrication capability. The tribological and
chemical characteristics of the [poly(MPC-co-BMA)] coating
increased the overall efﬁcacy of PU for clinical applications. In
addition, ultraviolet light treating technology have also been
employed to fabricate low friction catheter materials [107].
3.2. Structure design
3.2.1. Ventricular assist devices
Optimization the structure design is another approach to
reduce mechanical wear and friction in cardiovascular device.
The typical example is the ventricular assist devices (VADs).
Ventricular assist devices are generally classiﬁed into ﬁrst,
second or third generation designs in their development
process. Every emergence of a new generation design reduceswear and friction in VADs. The early design of VADs features
pulsatile pump technology because pulsatility is believed to be
necessary for organ perfusion and recovery. This pulsatile
pump requires a larger housing unit and contains a number of
moving components, such as unidirectional valves, motor,
actuator bearing and pusher et al. All of the moving parts are
subject to wear and tear which limit their durability
[12,108,109]. Subsequent generations of VADs adopt contin-
uous ﬂow pumps which have no unidirectional valves and
other moving parts, which existed in the pulsatile pump.
Mechanical wear only occurs at contact surface of bearing
system [110]. Third generation of devices is centrifugal
continuous ﬂow pumps with an impeller or rotor suspended
in the blood ﬂow path using either magnetic or hydrodynamic
levitation [111]. This design eliminates component-to-
component contact, thus reducing frictional wear, heat genera-
tion and theoretically increasing device durability and relia-
bility. Third generation pumps with suspension impeller or
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bearings which are susceptible to shock loads, such as in a car
accident, in which high decelerating forces are imposed [43].
To beneﬁt more heart failure patients, there is a need to
develop long-term VADs which can be implanted via mini-
mally invasive procedure. Recently, expandable/deployable
devices have been investigated as a potential solution [112].
Such a device can be inserted percutaneously via the peripheral
vessels in its collapsed form and operate in its expanded form
at the desired location. Hsu et al. [84] have reported that the
foldable pumps have less blood damage and mechanical wear
compared with current miniature percutaneous VADs.3.2.2. Mechanical heart valve
Mechanical valve design has evolved from the ﬁrst genera-
tion caged-ball design, to the improved tilting disc design, and
then to the contemporary bi-leaﬂet design. Bileaﬂet valves
currently dominate the mechanical valve market with a 90%
market share in the U.S. due to their superior performance
[113]. Despite the success of bileaﬂet valves, there is still a
wide margin for improvement in the existing designs [114].
For example, the hinge design which presents the most critical
elements, because wear occurs mainly at these points.
The Sorin Bicarbon valve has been carefully designed to
minimize the problem of friction by an innovative hinge design
based on a rolling rather than a sliding motion of spherical
surface of the leaﬂet pivot into a recess of the housing, as
shown in Fig. 10 [115]. This recess has a spherical bottom with
a larger radius than that of the pivot. This design theoretically
eliminates friction and wear, and allows for continuous blood
ﬂow through the hinges to maintain good washing even when
the valve is closed and thus reduces the risk of thrombus
formation [116].
To further reduce platelet activation or hemolysis, blood
ﬂow through the valve has to avoid stagnation zones and high
shear stress zones [114]. However, an in vivo/in situ analysis
on the subtle differences of velocity patterns and distribution
of shear stress are very difﬁcult. Fortunately, numerical
simulation of the blood ﬂow provides relevant insights into
the valve dynamics and can be used to optimize the design of
artiﬁcial heart valves [72,117]. With the development ofFig. 10 Sorin Bicarbon's rolling coupling kinematics between valve housing
(A) and leaﬂet pivot (B). o; o0are sphere centers; r; r0 are sphere radii; P0 is
contact point and center of instantaneous rotation; S is plane traced by the
rolling sphere [115].computational ﬂuid dynamics (CFD) and numerical algorithms
that account for the interaction between the ﬂuid and the valve
leaﬂets (ﬂuid–structure interaction (FSI)) [118–121], “virtual
bench tests” are more and more used in the different valve
design. This methodology offers many advantages, as the
valves can be tested side by side using precise control
parameters and applying the same boundary conditions. This
numerical methodology can also be used to assess the effects
of design parameters on the ﬂow induced thrombogenic
potential of blood recirculating devices. Dumont et al. [114]
have studied the hemodynamic and thrombogenic performance
of two bileaﬂet mechanical heart valves using a CFD/FSI
model. The numerical results indicate that the designs of the
ATS and SJM valves, which differ mainly in their hinge
mechanism, lead to different potential for platelet activation,
especially during the regurgitation phase.
State of the art methods for simulation ﬂuid–structure
interaction (FSI) in heart valves have reviewed by Borazjani
[122], and the ﬂow physics uncovered by FSI simulations are
discussed. Actually, numerical simulations are also used to
assistant design other cardiovascular devices, such as coronary
stents [123] and ventricular assist devices [124] et al. These
details can be seen in related papers [125–127]. In a word,
computational ﬂuid dynamics (CFD) is an attractive tool, it can
be used to optimize the design of cardiovascular devices with
the aim of reducing damage by mechanical wear or shear
stress.
3.2.3. Stents
Experimental and clinical evidence suggests that alteration
of ﬂuid wall shear stress (WSS) contributes to the occurrence
of in-stent restenosis (ISR) [128]. Speciﬁcally, it has been
observed clinically that the sites of neointimal hyperplasia (IH)
highly correlate with sites of low WSS [129]. It has been
reported that minimum wall shear stress decreased by 77% in
stented vessels compared to non-stented vessels [130]. The
stent design is known to affect the distribution of the WSS
imparted on the vessel wall [130,131], thereby optimizing the
geometry that minimizes stent-induced low WSS can further
improve the clinical outcomes of stent implantation.
Gundert et al. [132] have applied computational ﬂuid
dynamics (CFD) to determine the optimal number of circum-
ferentially repeating stent cells (NC) for slotted-tube stents
with various diameters and intrastrut areas. Optimal stent
design is deﬁned as those minimizing the area of low intrastrut
time-averaged WSS. The results show that the optimal value of
NC is dependent on the intrastrut angle with respect to the
primary ﬂow direction. Further investigation indicates that
stent designs with an intrastrut angle of approximately 401
minimized the area of low time-averaged WSS regardless of
vessel size or intrastrut area. Hsiao et al. [133] have reported
that wall shear stress is very sensitive to strut thickness, while
varying the strut width or crown radius has very little effect. A
thinner stent design does improve the stent haemodynamic
behavior. Balossino et al. [134] have investigated the hemo-
dynamic effects induced by two different thickness values for
the same stent design, and the result shows a reduced extension
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with a thicker strut. Chen et al. [128] have reported that
optimal stenting requires correct sizing of the stents, as both
oversizing and undersizing are highly inductive to neointimal
hyperplasia (IH) and may additionally create local conditions
that predispose to thrombosis. These ﬁndings may also lead to
improved stent designs that reduce strut induced ﬂow
disturbances.
4. Progress in the lubrication property of human blood
Human blood is a multiphase suspension with vital signs, as
well as a kind of complex non-Newtonian ﬂuid [135]. As a
lubricant, its lubrication property is not only concerned with
macro rheological properties of blood, but also closely related
to the rheological properties of the hemocytes (suspended
particles in blood), deformability, aggregation behavior, hemo-
lysis and thrombus, blood adhesion property and other factors.
In 1959, the ﬁrst blood constitutive equation was established
by Casson [136], and then developed by Luo [137], Walburn
[138], Quemada [139] and Thurston et al. [140]. Blood
constitutive equation reﬂects the rheological properties of
blood from a macroscopic perspective and provides a theore-
tical basis for research on the ﬂow characteristics of blood and
the dynamic pressure characteristics of blood lubrication. In
addition, the hemocyte model has also been established which
includes a structure mechanical model of single blood cells
[141,142], multi-blood cell aggregation/disaggregation model
and blood cell adhesion model [143,144]. These hemocyte
models lay a foundation for studying hemocyte's deformabil-
ity, rheological properties and broken rules from microscopic
perspective. The tribology of capillary blood ﬂow have been
reported, in which red blood cell deformation model have been
used [145].
As a lubricant, blood is regarded as a kind of homogeneous
liquid lubricant in mechanical terms, whose carrying capacity
can be determined by general means, for example, blood’s
lubrication property can be determined by the four-ball
machine [146]. From a medical point of view, blood is a kind
of substance with vital signs, when used as a lubricant, its
physiological indicators must not be damaged or the extent of
damage must be permissible medically. Therefore, the dama-
ging effect of friction and lubrication on blood components
should be taken fully into account while determining blood
lubrication indicators. Currently, there is no uniﬁed regulation
on the indicators for evaluating blood lubrication property, but
some scholars, such as Long et al. [147] have put forward the
basic conditions to ensure efﬁcient blood lubrication: (1) the
biological indicators of blood must be ensured, i.e. controlling
thrombus and hemolysis; (2) the lubricating ﬁlm of blood must
remain non-ruptured, i.e. staying in the state of ﬂuid lubrica-
tion; (3) the temperature in lubrication area must be within the
physiologically permitted range.
At present, the research on blood’s friction and lubrication
property is still in an exploratory stage. The emerging artiﬁcial
blood pump has adopted blood for lubrication. The valve
leaﬂet and valve ring of artiﬁcial heart valves also producewear and tear directly in blood, but there are very few studies
on the mechanism of blood friction and lubrication. In 1997,
Walowit et al. [44] did research on CCF's new blood pump, the
rotor bearing of which used blood directly for lubrication.
They optimized the bearing's structure parameters by simula-
tion methods. In 1998, Malanoski et al. [148] studied the usage
of magnetic bearing in such blood pump. Their experimental
and calculation results showed that, when blood lubricating
ﬁlm was thicker, the shaft-bearing system did not cause
vibration, at this moment, the axis of rotating shaft stayed in
the magnetic load side and formed a hydrodynamic pressure
there. Hereby they calculated the lubrication ﬁlm thickness
necessary for radial sliding bearing to ensure hypotonic
hemolysis under low shear. In 2005, Gong et al. [149]
synthesized blood's mechanical and physiological indicators
when studying miniature implantable blood pump, and put
forward the lubrication domain of blood as a lubricant. In
2006, based on the hydrodynamics theory and combined with
the rheological properties of blood, they established the blood
lubrication model under the conditions of high-shear steady-
state loading [150]. In 2007, they tested plasma’s carrying
capacity by four-ball method and analyzed the lubrication
property of plasma. The result showed that blood plasma has
good lubricant property, and its loading capacity can reach to
390 N [151]. In 2009, Long et al. [152] studied the friction on
the surface of red blood cells by atomic force microscopy. The
result showed that erythrocyte morphology had deﬁnite
inﬂuence on the micro-friction, and moisture, plasma and
surface charge adsorbed on the erythrocyte surface also have
some effect on the friction force of the blood cell. In 2012, Liu
et al. [153] studied the lubrication and action mechanism of the
blood to the biological titanium alloy. The results showed that
the bigger the hematocrit of blood, the better the lubrication to
the alloy surface was; and the rougher alloy surfaces, the better
lubrication of the blood on their surface at the micron range of
Ra was. On the whole, all above studies are mainly conducted
from the macro point of view, with no research on the
mechanism of blood friction and lubrication from microscopic
perspective.5. Future outlook
A great deal of bio-tribological problems exits in the various
cardiovascular devices which may cause the device failure or
bring about complications such as hemolysis and thrombosis.
The key for developing highly reliable cardiovascular devices
is to fully understand the friction and wear mechanism of the
artiﬁcial organs in contact with blood. But so far, we are
unable to directly observe and online monitor these tribological
behaviors, so, the topic of research about the friction-wear
testing methods of cardiovascular devices under simulated
human biological conditions needs to be vigorously promoted
in the future [154]. In addition, the structure design optimiza-
tion of cardiovascular devices and the material optimization of
friction pairs are perpetual topics in the research and develop-
ment of cardiovascular devices.
D. Xie et al. / Biosurface and Biotribology 1 (2015) 249–262 259As far as the lubrication property of human blood, the
existing researches are mainly from the view of macroscopic
tribology. The research on the basic theories of blood lubrica-
tion based on cell biomechanics, the inﬂuences of the physical
environment on the biological behavior of the hemocytes and
their lubrication property are relatively scarce [155]. In future,
it is necessary to establish a hemocyte equivalent mechanical
model for tribology research, and it is necessary to analyze the
biomechanical behaviors (deformation, adhesion, distribution,
movement) between hemocytes and the material surface from a
microscopic perspective.Acknowledgments
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